|
|
|
|
|
|
| Available: Yes* |
| This title does not qualify for any discount. |
|
Other formats:
|
| Edition: | 1st |
| Publisher: | National Academies Press |
| ISBN: | 0-309-09229-9 (0309092299) |
| ISBN-13: | 978-0-309-09229-6 (9780309092296) |
| Format: | Proceedings MARCH 2021 |
| Binding: | E E Book + ProQuest Ebook Central |
| Copyright: | 2021 |
| Publish Date: | 01/22 |
| Weight: | 0.00 Lbs. |
| Subject Class: | PUB (Public Health) |
| Return Policy: | Non-Returnable. |
| |
|
| ProQuest Ebook Central�: |
Please sign in to preview this title
|
|
|
| |
| Discipline: | Pharmacology | | Subject Definition: | Drug Discovery; Chronic Disease | | NLM Class: | QV 744 | | LC Class: | RM301.25 | | Abstract: | Investment and innovation in drug research and development (R&D) for highly prevalent chronic diseases has stalled in recent decades, despite half of all Americans living with at least one chronic disease. As a result, prevalent chronic diseases are producing immense health care costs as well as preventable suffering and death. On February 22, March 2, and March 8, 2021, the National Academies of Sciences, Engineering, and Medicine, convened a workshop to discuss barriers to innovation in this space and examine strategies and incentives to support equitable, person-centered drug R&D for prevalent chronic diseases. |
|
|
* Subject to ProQuest Ebook Central� availability |
|
|
|
|
|
Follow Matthews Book Co. on:
Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews